The Haploinsufficient Col3a1 Mouse as a Model for Vascular Ehlers-Danlos Syndrome

Veterinary Pathology

Volumn 47, Issue 6, 2010, Pages 1028-1039

  Cooper, T K ^a   Zhong, Q ^a   Krawczyk, M ^b   Tae, H J ^b   Muller G A ^b,e   Schubert, R ^c   Myers, L A ^d   Dietz, H C ^d   Talan, M I ^b   Briest, W ^b,e  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Col3a1; haploinsufficient; Mouse model; vascular Ehlers Danlos

Indexed keywords

COLLAGEN TYPE 3;

ANIMAL; AORTA; ARTERY; ARTICLE; BLOOD VESSEL; COLON; DISEASE MODEL; EHLERS DANLOS SYNDROME; FEMALE; GENETICS; GENOTYPE; HAPLOINSUFFICIENCY; HETEROZYGOTE; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; AORTA; ARTERIES; BLOOD VESSELS; BLOTTING, WESTERN; COLLAGEN TYPE III; COLON; DISEASE MODELS, ANIMAL; EHLERS-DANLOS SYNDROME; FEMALE; GENOTYPE; HAPLOINSUFFICIENCY; HETEROZYGOTE; MALE; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; MUS;

EID: 78649916092     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810374842     Document Type: Article

References (40)

1. Arteaga-Solis E., Gayraud B., Ramirez F.: Elastic and collagenous networks in vascular diseases. Cell Struct Funct 25:69-72, 2000.
2. Barabas AP: Ehlers-Danlos syndrome type IV. N Engl J Med 343:366; author reply 368, 2000.
3. Baxter BT: Heritable diseases of the blood vessels. Cardiovasc Pathol 14:185-188, 2005.
4. Beighton P., De Paepe A., Steinmann B., Tsipouras P., Wenstrup RJ: Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77:31-37, 1998.
5. Blaker H., Funke B., Hausser I., Hackert T., Schirmacher P., Autschbach F.: Pathology of the large intestine in patients with vascular type Ehlers-Danlos syndrome. Virchows Arch 450:713-717, 2007.
6. Bornstein P.: The NH(2)-terminal propeptides of fibrillar collagens: highly conserved domains with poorly understood functions. Matrix Biol 21:217-226, 2002.
7. Collins MH, Schwarze U., Carpentieri DF, Kaplan P., Nathanson K., Meyer JS, Byers PH: Multiple vascular and bowel ruptures in an adolescent male with sporadic Ehlers-Danlos syndrome type IV. Pediatr Dev Pathol 2:86-93, 1999.
8. Dahi S., Lee JG, Lovett DH, Sarkar R.: Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin. J Vasc Surg 42:539-545, 2005.
9. Deatrick KB, Eliason JL, Lynch EM, Moore AJ, Dewyer NA, Varma MR, Pearce CG, Upchurch GR, Wakefield TW, Henke PK: Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. J Vasc Surg 42:140-148, 2005.
10. Germain DP: Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg 16:391-397, 2002.
11. Germain DP: Ehlers-Danlos syndrome type IV. Orphanet J Rare Dis 2:32, 2007.
12. Goergen CJ, Johnson BL, Greve JM, Taylor CA, Zarins CK: Increased anterior abdominal aortic wall motion: possible role in aneurysm pathogenesis and design of endovascular devices. J Endovasc Ther 14:574-584, 2007.
13. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L., Klein EC, Liu G., Calvi C., Podowski M., Neptune ER, Halushka MK, Bedja D., Gabrielson K., Rifkin DB, Carta L., Ramirez F., Huso DL, Dietz HC: Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121, 2006.
14. Harkness ML, Harkness RD, McDonald DA: The collagen and elastin content of the arterial wall in the dog. Proc R Soc Lond B Biol Sci 146:541-551, 1957.
15. Jain D., Dietz HC, Oswald GL, Maleszewski JJ, Halushka MK: Causes and histopathology of ascending aortic disease in children and young adults [published online ahead of print November 18, 2009]. Cardiovasc Pathol.
16. Jones JA, Spinale FG, Ikonomidis JS: Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res 46:119-137, 2009.
17. Judge DP, Biery NJ, Keene DR, Geubtner J., Myers L., Huso DL, Sakai LY, Dietz HC: Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest 114:172-181, 2004.
18. Liu X., Wu H., Byrne M., Krane S., Jaenisch R.: Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci U S A 94:1852-1856, 1997.
19. Loeys BL, Chen J., Neptune ER, Judge DP, Podowski M., Holm T., Meyers J., Leitch CC, Katsanis N., Sharifi N., Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J., Hellemans J., Chen Y., Davis EC, Webb CL, Kress W., Coucke P., Rifkin DB, De Paepe AM, Dietz HC: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275-281, 2005.
20. Loeys BL, Schwarze U., Holm T., Callewaert BL, Thomas GH, Pannu H., De Backer JF, Oswald GL, Symoens S., Manouvrier S., Roberts AE, Faravelli F., Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC: Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 355:788-798, 2006.
21. Maleszewski JJ, Miller DV, Lu J., Dietz HC, Halushka MK: Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). Am J Surg Pathol 33:194-201, 2009.
22. Mathy JA, Lenton K., Nacamuli RP, Fong KD, Song HM, Fang TD, Yang GP, Longaker MT: FGF-2 stimulation affects calvarial osteoblast biology: quantitative analysis of nine genes important for cranial suture biology by real-time reverse transcription polymerase chain reaction. Plast Reconstr Surg 112:528-539, 2003.
23. Parapia LA, Jackson C.: Ehlers-Danlos syndrome-a historical review. Br J Haematol 141:32-35, 2008.
24. Pepin M., Schwarze U., Superti-Furga A., Byers PH: Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342:673-680, 2000.
25. Pereira L., Lee SY, Gayraud B., Andrikopoulos K., Shapiro SD, Bunton T., Biery NJ, Dietz HC, Sakai LY, Ramirez F.: Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A 96:3819-3823, 1999.
26. Plancke A., Holder-Espinasse M., Rigau V., Manouvrier S., Claustres M., Van Kien PK: Homozygosity for a null allele of COL3A1 results in recessive Ehlers-Danlos syndrome [published online ahead of print May 20, 2009]. Eur J Hum Genet 2009;17:1411-1416.
27. Popov Y., Patsenker E., Fickert P., Trauner M., Schuppan D.: Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 43:1045-1054, 2005.
28. Rahkonen O., Su M., Hakovirta H., Koskivirta I., Hormuzdi SG, Vuorio E., Bornstein P., Penttinen R.: Mice with a deletion in the first intron of the Col1a1 gene develop age-dependent aortic dissection and rupture. Circ Res 94:83-90, 2004.
29. Ramot Y., Manno RA, Okazaki Y., Krakovsky M., Lamensdorf I., Meiron M., Toren A., Zehavi-Goldstein E., Vezzali E., Nyska A.: Spontaneous aortitis in the Balb/c mouse. Toxicol Pathol 37:667-671, 2009.
30. Schlatmann TJ, Becker AE: Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 39:13-20, 1977.
31. Schlatmann TJ, Becker AE: Pathogenesis of dissecting aneurysm of aorta. Comparative histopathologic study of significance of medial changes. Am J Cardiol 39:21-26, 1977.
32. Schwarze U., Schievink WI, Petty E., Jaff MR, Babovic-Vuksanovic D., Cherry KJ, Pepin M., Byers PH: Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV. Am J Hum Genet 69:989-1001, 2001.
33. Seeland U., Selejan S., Engelhardt S., Muller P., Lohse MJ, Bohm M.: Interstitial remodeling in beta1-adrenergic receptor transgenic mice. Basic Res Cardiol 102:183-193, 2007.
34. Singh RJ, Mason JC, Lidington EA, Edwards DR, Nuttall RK, Khokha R., Knauper V., Murphy G., Gavrilovic J.: Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res 67:39-49, 2005.
35. Stella A., Gessaroli M., Cifiello BI, Mirelli M., Loperfido V., Riva R., Guizzardi S.: Sack-Barabas syndrome (Ehlers-Danlos IV type) (clinic and histopathologic ultrastructural correlations). Vasc Surg 20:67-73, 1986.
36. Stevenson K., Kucich U., Whitbeck C., Levin RM, Howard PS: Functional changes in bladder tissue from type III collagen-deficient mice. Mol Cell Biochem 283:107-114, 2006.
37. Towbin JA, Casey B., Belmont J.: The molecular basis of vascular disorders. Am J Hum Genet 64:678-684, 1999.
38. van Eys GJ, Niessen PM, Rensen SS: Smoothelin in vascular smooth muscle cells. Trends Cardiovasc Med 17:26-30, 2007.
39. Watanabe A., Shimada T.: Vascular type of Ehlers-Danlos syndrome. J Nippon Med Sch 75:254-261, 2008.
40. Wolinsky H., Glagov S.: A lamellar unit of aortic medial structure and function in mammals. Circ Res 20:99-111, 1967.